Dr. Robert (“Bob”) Hogg was officially inducted into the Order of Canada on February 1st, an accomplishment he doesn’t just see as an award but as a national responsibility. “It’s very humbling, especially when you start to meet other people who have been inducted, to be a part of that group,” he said. Dr. Hogg’s […]
Celebrated BC-CfE researcher Dr. Robert Hogg named to Order of Canada Read More »
HIV Monitoring Quarterly Report for British Columbia, Fourth Quarter 2018 HIV Monitoring Quarterly Report for Fraser Health, Fourth Quarter 2018 HIV Monitoring Quarterly Report for Interior Health, Fourth Quarter 2018 HIV Monitoring Quarterly Report for Northern Health, Fourth Quarter 2018 HIV Monitoring Quarterly Report for Vancouver Coastal Health, Fourth Quarter 2018 HIV Monitoring Quarterly Report
HIV Monitoring Quarterly Reports, Fourth Quarter 2018 Read More »
Readmission within 30 days of discharge from the hospital is associated with adverse health outcomes, and the 30-day readmission rate serves as an important barometer of a hospital’s quality of care.1 Hospital readmissions also represent a significant financial burden. The Agency for Healthcare Research and Quality estimated that in 2011, more than 3 million US
Better Physician-Patient Relationship Reduces Hospital Readmissions for PLWHIV Read More »
VANCOUVER (NEWS 1130) – Another tool in the fight against the opioid crisis across B.C. has been unveiled. Vancouver Coastal Health has teamed up with the B.C. Centre for Excellence in HIV/AIDS to roll out Best Practices in Oral Opioid Agonist Therapy (BOOST) province-wide to combat overdose deaths. The goal of the 18-month pilot project
First-of-its kind program aims to stop overdose deaths across B.C. Read More »
Following a successful pilot project in Vancouver, an overdose prevention program is now rolling out province-wide. For the past year the BC Centre for Excellence in HIV/AIDS has been assisting Vancouver Coastal Health with BOOST (Best Practice is Oral Opioid Agonist Therapy). The project applied some of the same strategies used to reduce the spread
VANCOUVER – An 18-month pilot project is being expanded across British Columbia after more than double the number of drug-addicted people stayed in treatment to stop them from fatally overdosing. The initiative, led by the BC Centre for Excellence in HIV/AIDS and Vancouver Coastal Health, uses the same strategy that helped drive down the province’s
Project that kept more addicted patients in treatment expands across B.C. Read More »
The initiative, led by the BC Centre for Excellence in HIV/AIDS and Vancouver Coastal Health, uses the same strategy that helped drive down the province’s HIV and AIDS rates. A pilot project in Vancouver is being expanded across British Columbia after more than double the number of drug-addicted people stayed in treatment to prevent them
Project that kept more drug-addicted patients in treatment expands across B.C. Read More »
A first-of-its-kind opioid addiction treatment program, first piloted in Vancouver, will soon roll out across the rest of the province as B.C. grapples with nearly 2,800 overdose deaths since 2017. In a news conference Thursday, members of the BC Centre for Excellence in HIV/AIDS and Vancouver Coastal Health released results from a one-year pilot program
B.C. opioid crisis to get same world-renowned treatment approach as HIV/AIDS Read More »
Patients can obtain a test without having to visit a physician Getting tested for human immunodeficiency virus (HIV) just got easier for residents across the Interior Health (IH) region, now that On Demand testing is available at all IH laboratories (http://bit.ly/2PD39aL). Patients can now visit any IH lab – including the labs at the Ashcroft
On Demand HIV testing now available at all Interior Health labs Read More »
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
